Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Clinical Trial of Vormatrigine in Adult Patients With Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Vormatrigine in adult patients with epilepsy is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vormatrigine (Vormatrigine)

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Epilepsy, Tonic-Clonic, Focal Seizure | Phase 3 | Status: ENROLLING_BY_INVITATION